Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies. - Wikidata - awgldk - TriplyDB

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.

http://www.wikidata.org/entity/Q39108760

about

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses.Germinal center enhancement by extended antigen availability.A novel polyepitope vaccine elicited HIV peptide specific CD4+ T cell responses in HLA-A2/DRB1 transgenic mice.The quest for an antibody-based HIV vaccine.B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection.Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.Regulatory T cells in retroviral infections.Advances in HIV-1 Vaccine Development.HIV Vaccination: A Roadmap among Advancements and Concerns.The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination.Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins.HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses Frequencies of Circulating Th1-Biased T Follicular Helper Cells in Acute HIV-1 Infection Correlate with the Development of HIV-Specific Antibody Responses and Lower Set Point Viral Load High-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not Adults Accidental Father-to-Son HIV-1 Transmission During the Seroconversion Period

P2860

Q38659433-4EC28B54-BEC9-4CA7-9C8C-844A28AA35B7 Q39454581-3B85C6B6-F8A7-4E50-933E-B126936B5692 Q40061333-FA822843-105F-409E-AEAA-86B15BFCFBCD Q40354016-AF973EAB-8ABC-4A58-B46D-FA070FEB7A0D Q47169594-AC9C0329-EA40-4165-96B3-8F67AAFEE0C4 Q47548910-2FA0EA4D-5965-4DD4-ABED-B9F6CFEB29DC Q49979151-FE4E0536-435B-4D3B-8420-2C8B53D709F2 Q52609661-2E5BEFCB-6D19-4ADD-8654-689FE13BCB68 Q54232567-4F6D7F51-4475-4F55-B491-3A6067C8D5EC Q54249832-89D3FF6F-4B65-4BD1-B3E5-A4E31458249C Q55401174-5945E87B-7F37-4568-A16B-B6CD5F402E3B Q57071746-2FBD8C1E-CC06-4810-A796-E2689F812CFC Q57170667-EDF8FF25-D527-415B-84BE-0CE3317DCC71 Q57206379-718B9859-4D0C-4A27-BBFE-9BD96E2D0A87 Q58746597-3BA94D3F-0852-4F8D-A5DB-E937C311C26D Q58870939-5D00657D-7190-435E-9B7E-A5648D7E626B

P2860

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.

http://www.wikidata.org/entity/Q39108760

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Immunologic characteristics of ...... oadly neutralizing antibodies.

@en

Immunologic characteristics of ...... oadly neutralizing antibodies.

@nl

type

label

Immunologic characteristics of ...... oadly neutralizing antibodies.

@en

Immunologic characteristics of ...... oadly neutralizing antibodies.

@nl

prefLabel

Immunologic characteristics of ...... oadly neutralizing antibodies.

@en

Immunologic characteristics of ...... oadly neutralizing antibodies.

@nl

P1433

Q39108760-81715534-CBAF-4957-904C-3CA86E206C3F

P1476

Q39108760-C1896279-DD7A-4C9F-B173-2B9E8DB98C9A

P2093

Q39108760-AC168E1D-1B51-4BEB-B9F7-D763433A981C

P275

Q39108760-FF32E0E6-9631-4CE9-AEEF-2F311A473448

P2860

Q39108760-01DFD4BB-8325-41B3-B3BE-BD07B65D17A9

Q39108760-01EA5BD7-5456-4737-BD2D-B574D9BC29F4

Q39108760-0398AF26-EA92-4AE1-9D51-45BA6E22350C

Q39108760-046E0804-5329-4672-B6F0-FEDC4EBDA100

Q39108760-0539DE49-19F1-49BE-B0ED-D621E55BB930

Q39108760-05A2458C-2A2B-4212-B495-BDC0331BC267

Q39108760-05F448D1-4116-4C63-8801-BDEB1C68020C

Q39108760-07B6D516-A658-4212-A8F4-572B5D4BB84F

Q39108760-07D6578F-EDCD-46E2-BDC9-B14BF22EA9F9

Q39108760-08A192E7-DE27-4884-ADF6-EFB7CD383639

P304

Q39108760-7F91EEFC-F786-45B9-A309-65CD5D8710A7

P31

Q39108760-DEBCA9E9-738A-4C47-A468-DF8BB0EC1783

P356

Q39108760-1F6A0D11-DD31-4996-A8BF-1E7FB2170FCA

P433

Q39108760-7F8DD7E8-359A-4753-AD2D-11ADB058D1C2

P478

Q39108760-4A9898CA-F67C-4A52-BDA8-A189BC319E97

P50

Q39108760-9391BD66-C289-43A6-8D9B-E3D52AFC2F29

P5008

Q39108760-3F0BDDFD-B4DF-44CB-8EB7-B770501531B5

P577

Q39108760-37DDF02F-4EF2-4E46-9657-4A22C1360BBD

P698

Q39108760-4E46680B-3DB4-47C3-8E15-7BDB2B5FF1AC

P921

Q39108760-0B5E4B10-F714-4BD1-AEFE-1A4A16F28CD7

Q39108760-1FF78338-09E5-4748-96ED-39C433919743

Q39108760-28323696-AE7E-4843-89C6-DCD7B719533B

Q39108760-2C687F1E-2E95-4D68-BB59-83A2F21A20BB

Q39108760-5375DE09-4E9D-4411-83C0-C45931CDC261

Q39108760-8D567E33-2786-4BD8-8E17-73C62EC04D74

Q39108760-ABE737F9-267C-4ABD-B72F-C813C5105351

Q39108760-B474740B-00A0-4A8F-91F8-DF06AB8613BD

Q39108760-BD4446AF-4599-496A-907C-E5DA3C56B5F1

P932

Q39108760-ADA28A8C-8080-4523-B613-6DD77344CED4

P356

P1433

Immunological Reviews

P1476

Immunologic characteristics of ...... roadly neutralizing antibodies

@en

P2093

M Anthony Moody

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150)

The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells

A Blueprint for HIV Vaccine Discovery

Antibody responses to envelope glycoproteins in HIV-1 infection

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization

P304

62-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IMR.12504

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

275

http://www.w3.org/2001/XMLSchema#string

P50

Persephone Borrow

P5008

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28133804

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

lymphatic tissue

lymphocyte subsets

hemic and immune systems

P932

5299500

http://www.w3.org/2001/XMLSchema#string